Triamcinolone acetonide

Producers Shown on SFDA

Producer:Tianjin Jinhui Pharmaceutical Group Co., Ltd. is a state-owned holding enterprise, specializing in the production of corticosteroid APIs with the quality of triamcinolone acetonide, triamcinolone acetonide acetate, prednisone acetate, hydrocortisone acetate and other products. The company organizes production according to the GMP standard, and its quality has been recognized by internationally renowned pharmaceutical manufacturers. It has advanced production equipment, strong technical force, first-class testing means, and products meet the standards of domestic and foreign pharmacopoeia such as BP/USP/EP/CP.

Staff:50-99 persons

Registered capital:33.69 million 

Producer:Tianjin Tianyao Pharmaceutical Co., Ltd. (hereinafter referred to as "Tianyao Shares" and "the Company") was established on December 1, 1999. The predecessor of 2Tianyao is Tianjin Pharmaceutical Factory, which was founded in 1939. Since the 1950s and 1960s, it has taken the lead in developing, developing and producing corticosteroid APIs in China. It is one of the pioneers of corticosteroid drugs in China and an influential research, production and export base of corticosteroid APIs in China. In 2017, the company completed the reorganization project of acquiring Tianjin Jinyao Pharmaceutical Co., Ltd. (hereinafter referred to as "Jinyao Pharmaceutical"), and realized the strategic transformation from a single "API" to a "API and preparation" business with complementary advantages and two rounds of linkage. In 2020, the company acquired 51% of the equity of Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Co., Ltd. (hereinafter referred to as "Hubei Tianyao"). Hubei Tianyao mainly produces and sells small volume injections and large volume injections, further enriching the company's product categories, expanding the scale of preparation products, and driving force of performance under the dual wheel linkage model of "APIs and preparations" is more significant.
The company now has 17 holding and participating companies, with total assets of more than 6 billion yuan. The company's main products include more than 40 kinds of corticosteroid APIs such as dexamethasone series, prednisone series, methylprednisolone series and betamethasone series, 23 kinds of amino acid APIs, and 16 dosage forms such as tablets, small volume injections, ointments, creams, films, gel, films, suppositories, hard capsules, pills, freeze-dried powder injections.

Staff:100-199 persons

Registered capital:1096.36 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978